J. Pons

Publications23
h-index14
Citations1,111
Highly Influential Citations59
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • Z. Żukowska
  • 64 Publications • 2,552 Citations
  • Z. Żukowska-Grójec
  • 97 Publications • 3,960 Citations
  • L. Edvinsson
  • 1,077 Publications • 39,744 Citations
  • H. Herzog
  • 373 Publications • 17,248 Citations
  • Publications
  • Influence
Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors.
Neuropeptide Y (NPY) is a sympathetic neurotransmitter recently found to be potently angiogenic and growth promoting for endothelial, vascular smooth muscle and neuronal cells. NPY and its cognate… Expand
  • 125
  • 15
  • PDF
Temporal dissection of tumorigenesis in primary cancers.
Timely intervention for cancer requires knowledge of its earliest genetic aberrations. Sequencing of tumors and their metastases reveals numerous abnormalities occurring late in progression. A means… Expand
  • 204
  • 11
  • PDF
Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system?
Neuropeptide Y (NPY(1-36)), a sympathetic cotransmitter and neurohormone, has pleiotropic activities ranging from the control of obesity to anxiolysis and cardiovascular function. Its actions are… Expand
  • 115
  • 5
CGRP function‐blocking antibodies inhibit neurogenic vasodilatation without affecting heart rate or arterial blood pressure in the rat
Calcitonin gene‐related peptide (CGRP) receptor antagonists effectively abort migraine headache and inhibit neurogenic vasodilatation in humans as well as rat models. Monoclonal antibodies typically… Expand
  • 77
  • 5
Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system.
Neuropeptide Y (NPY), a sympathetic cotransmitter and vasoconstrictor, also stimulates vascular smooth muscle cell (VSMC) growth, but which of its Y1-Y5 receptors are involved remains unclear. In… Expand
  • 70
  • 4
VEGF improves survival of mesenchymal stem cells in infarcted hearts.
Bone marrow-derived mesenchymal stem cells (MSC) are a promising source for cell-based treatment of myocardial infarction (MI), but existing strategies are restricted by low cell survival and… Expand
  • 125
  • 4
Interactions of multiple signaling pathways in neuropeptide Y-mediated bimodal vascular smooth muscle cell growth.
Neuropeptide Y (NPY), a sympathetic cotransmitter, acts via G protein-coupled receptors to stimulate constriction and vascular smooth muscle cell (VSMC) proliferation through interactions with its Y1… Expand
  • 41
  • 4
  • PDF
Green technologies for room temperature nucleic acid storage.
Maintaining the long-term integrity of nucleic acids in the laboratory has traditionally required the use of freezers. However, novel nucleic acid stabilization technologies may allow for the storage… Expand
  • 49
  • 4
  • PDF
Neuropeptide Y: multiple receptors and multiple roles in cardiovascular diseases.
Neuropeptide Y (NPY), a sympathetic co-transmitter, acts through multiple G protein-coupled receptors (Y1 to y6) to elicit its vast range of effects in the cardiovascular, immune, and central and… Expand
  • 46
  • 3
Neuropeptide Y-induced angiogenesis in aging
Age-related changes in NPY-driven angiogenesis were investigated using Matrigel and aortic sprouting assays in young (2 months.) and aged (18 months.) mice. In both assays, NPY-induced vessel growth… Expand
  • 58
  • 1
...
1
2
3
...